{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:46:54Z","timestamp":1792028814253,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Breast cancer patients receiving neoadjuvant treatment may benefit from a presurgical assessment of complete response to avoid unnecessary surgeries. We aimed to develop a machine learning model that predicts pathological complete response (pCR) based on results from different image modalities as well as tumor and patient characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical data from 388 cases of invasive breast cancer receiving neoadjuvant treatment were extracted in this retrospective, monocentric study. Findings from ultrasound, mammography and magnetic resonance imaging combined with patient and histopathological information were included. A Pearson Product-Moment correlation and a LASSO regularization were performed to preselect the most relevant features for the outcome. Based on the preselected variables, we developed and validated a machine learning algorithm (logistic regression with elastic net penalty (GLM)) to predict pCR. The model\u2019s performance was evaluated via area under the curve (AUROC), false positive rate (FPR) and positive predictive value (PPV).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the total cohort, pCR was detected in 158 out of 388 cases, resulting in a pCR rate of 40.7%. From 111 collected variables, 8 variables were removed due to a high correlation with other features. After the LASSO regularization, 14 variables were included as predictors for the final model. In the validation set, the GLM achieved an AUROC of 0.76 with a FPR of 8.7% and a PPV of 75%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Through the combination of imaging and clinicopathological features, our machine learning model shows a promising approach to improve the prediction of pCR in breast cancer patients receiving neoadjuvant treatment. In combination with the LASSO regularization, it allows interesting insights into the predictive potential of different variables, which are available as part of standard clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-026-17115-7","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:54:12Z","timestamp":1791438852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Machine learning model for the prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Eva","family":"Reisig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lie","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Sch\u00e4fgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Pfob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"issue":"13","key":"17115_CR1","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1200\/jco.20.03399","volume":"39","author":"LA Korde","year":"2021","unstructured":"Korde LA, Somerfield MR, Carey LA, Crews JR, Denduluri N, Hwang ES, et al. Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline. J Clin Oncol. 2021;39(13):1485\u2013505. https:\/\/doi.org\/10.1200\/jco.20.03399.","journal-title":"J Clin Oncol"},{"key":"17115_CR2","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft DK. AWMF). S3-Leitlinie Fr\u00fcherkennung, Diagnose, Therapie und Nachsorge des Mammakarzinoms. Version 4.4.2021. AWMF Registernummer: 032-045OL. Available from: [Accessed 23 December 2025] https:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/mammakarzinom\/"},{"issue":"5","key":"17115_CR3","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1245\/s10434-011-2108-2","volume":"19","author":"M Kaufmann","year":"2012","unstructured":"Kaufmann M, von Minckwitz G, Mamounas EP, Cameron D, Carey LA, Cristofanilli M, et al. Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer. Ann Surg Oncol. 2012;19(5):1508\u201316. https:\/\/doi.org\/10.1245\/s10434-011-2108-2.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"17115_CR4","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1007\/s11547-024-01783-1","volume":"129","author":"Z Li","year":"2024","unstructured":"Li Z, Liu X, Gao Y, Lu X, Lei J. Ultrasound-based radiomics for early predicting response to neoadjuvant chemotherapy in patients with breast cancer: a systematic review with meta-analysis. Radiol Med. 2024;129(6):934\u201344. https:\/\/doi.org\/10.1007\/s11547-024-01783-1.","journal-title":"Radiol Med"},{"key":"17115_CR5","doi-asserted-by":"publisher","first-page":"110574","DOI":"10.1016\/j.clinimag.2025.110574","volume":"125","author":"P Valizadeh","year":"2025","unstructured":"Valizadeh P, Jannatdoust P, Moradi N, Yaghoobpoor S, Toofani S, Rafiei N, et al. Ultrasound-based machine learning models for predicting response to neoadjuvant chemotherapy in breast cancer: A meta-analysis. Clin Imaging. 2025;125:110574. https:\/\/doi.org\/10.1016\/j.clinimag.2025.110574.","journal-title":"Clin Imaging"},{"issue":"1","key":"17115_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13058-020-01291-w","volume":"22","author":"EJ Sutton","year":"2020","unstructured":"Sutton EJ, Onishi N, Fehr DA, Dashevsky BZ, Sadinski M, Pinker K, et al. A machine learning model that classifies breast cancer pathologic complete response on MRI post-neoadjuvant chemotherapy. Breast Cancer Res. 2020;22(1):57. https:\/\/doi.org\/10.1186\/s13058-020-01291-w.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"17115_CR7","doi-asserted-by":"publisher","first-page":"e222830","DOI":"10.1148\/radiol.222830","volume":"308","author":"Z Shi","year":"2023","unstructured":"Shi Z, Huang X, Cheng Z, Xu Z, Lin H, Liu C, et al. MRI-based Quantification of Intratumoral Heterogeneity for Predicting Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer. Radiology. 2023;308(1):e222830. https:\/\/doi.org\/10.1148\/radiol.222830.","journal-title":"Radiology"},{"key":"17115_CR8","doi-asserted-by":"publisher","first-page":"101899","DOI":"10.1016\/j.eclinm.2023.101899","volume":"58","author":"Y Huang","year":"2023","unstructured":"Huang Y, Zhu T, Zhang X, Li W, Zheng X, Cheng M, et al. Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study. EClinicalMedicine. 2023;58:101899. https:\/\/doi.org\/10.1016\/j.eclinm.2023.101899.","journal-title":"EClinicalMedicine"},{"key":"17115_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1200\/cci.20.00078","volume":"5","author":"N Meti","year":"2021","unstructured":"Meti N, Saednia K, Lagree A, Tabbarah S, Mohebpour M, Kiss A, et al. Machine Learning Frameworks to Predict Neoadjuvant Chemotherapy Response in Breast Cancer Using Clinical and Pathological Features. JCO Clin Cancer Inf. 2021;5:66\u201380. https:\/\/doi.org\/10.1200\/cci.20.00078.","journal-title":"JCO Clin Cancer Inf"},{"key":"17115_CR10","doi-asserted-by":"publisher","first-page":"e2100055","DOI":"10.1200\/cci.21.00055","volume":"6","author":"RB Basmadjian","year":"2022","unstructured":"Basmadjian RB, Kong S, Boyne DJ, Jarada TN, Xu Y, Cheung WY, et al. Developing a Prediction Model for Pathologic Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer: A Comparison of Model Building Approaches. JCO Clin Cancer Inf. 2022;6:e2100055. https:\/\/doi.org\/10.1200\/cci.21.00055.","journal-title":"JCO Clin Cancer Inf"},{"issue":"3","key":"17115_CR11","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s10549-021-06310-8","volume":"189","author":"JY Kim","year":"2021","unstructured":"Kim JY, Jeon E, Kwon S, Jung H, Joo S, Park Y, et al. Prediction of pathologic complete response to neoadjuvant chemotherapy using machine learning models in patients with breast cancer. Breast Cancer Res Treat. 2021;189(3):747\u201357. https:\/\/doi.org\/10.1007\/s10549-021-06310-8.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"17115_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13058-024-01905-7","volume":"26","author":"F Zhao","year":"2024","unstructured":"Zhao F, Polley E, McClellan J, Howard F, Olopade OI, Huo D. Predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer using a machine learning approach. Breast Cancer Res. 2024;26(1):148. https:\/\/doi.org\/10.1186\/s13058-024-01905-7.","journal-title":"Breast Cancer Res"},{"issue":"8","key":"17115_CR13","doi-asserted-by":"publisher","first-page":"7206","DOI":"10.1245\/s10434-026-19670-6","volume":"33","author":"M M\u00fcller","year":"2026","unstructured":"M\u00fcller M, Heil J, Pfob A, Cai L, Reisig E, Togawa R, et al. Predictive Value of Routine Imaging for the Diagnosis of Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer. Ann Surg Oncol. 2026;33(8):7206\u201315. https:\/\/doi.org\/10.1245\/s10434-026-19670-6.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"17115_CR14","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12874-022-01758-8","volume":"22","author":"A Pfob","year":"2022","unstructured":"Pfob A, Lu SC, Sidey-Gibbons C. Machine learning in medicine: a practical introduction to techniques for data pre-processing, hyperparameter tuning, and model comparison. BMC Med Res Methodol. 2022;22(1):282. https:\/\/doi.org\/10.1186\/s12874-022-01758-8.","journal-title":"BMC Med Res Methodol"},{"issue":"12","key":"17115_CR15","doi-asserted-by":"publisher","first-page":"9385","DOI":"10.1002\/mp.17451","volume":"51","author":"B Jing","year":"2024","unstructured":"Jing B, Wang K, Schmitz E, Tang S, Li Y, Zhang Y, et al. Prediction of pathological complete response to chemotherapy for breast cancer using deep neural network with uncertainty quantification. Med Phys. 2024;51(12):9385\u201393. https:\/\/doi.org\/10.1002\/mp.17451.","journal-title":"Med Phys"},{"key":"17115_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2026.06.010","author":"T Jiang","year":"2026","unstructured":"Jiang T, Li X, Shen J, Yan Y, Sui L, Zhou L, et al. Early Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer using a Longitudinal US-based Stack-model. Acad Radiol. 2026. https:\/\/doi.org\/10.1016\/j.acra.2026.06.010.","journal-title":"Acad Radiol"},{"issue":"1","key":"17115_CR17","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1186\/s12885-025-14407-2","volume":"25","author":"Y Liang","year":"2025","unstructured":"Liang Y, Xu H, Lin J, Tang W, Liu X, Gan K, et al. Multi-modal radiomics model based on four imaging modalities for predicting pathological complete response to neoadjuvant treatment in breast cancer. BMC Cancer. 2025;25(1):985. https:\/\/doi.org\/10.1186\/s12885-025-14407-2.","journal-title":"BMC Cancer"},{"issue":"1","key":"17115_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40644-025-00929-2","volume":"25","author":"S Xu","year":"2025","unstructured":"Xu S, Ying Y, Hu Q, Li X, Li Y, Xiong H, et al. Fusion model integrating multi-sequence MRI radiomics and habitat imaging for predicting pathological complete response in breast cancer treated with neoadjuvant therapy. Cancer Imaging. 2025;25(1):108. https:\/\/doi.org\/10.1186\/s40644-025-00929-2.","journal-title":"Cancer Imaging"},{"key":"17115_CR19","doi-asserted-by":"publisher","unstructured":"Mali SA, Ibrahim A, Woodruff HC, Andrearczyk V, M\u00fcller H, Primakov S, et al. Making Radiomics More Reproducible across Scanner and Imaging Protocol Variations: A Review of Harmonization Methods. J Pers Med. 2021;11(9). https:\/\/doi.org\/10.3390\/jpm11090842.","DOI":"10.3390\/jpm11090842"},{"key":"17115_CR20","doi-asserted-by":"publisher","unstructured":"Li W, Onishi N, Gibbs JE, Wilmes LJ, Le NN, Metanat P, et al. MRI-Based Model for Personalizing Neoadjuvant Treatment in Breast Cancer. Tomography. 2025;11(3). https:\/\/doi.org\/10.3390\/tomography11030026.","DOI":"10.3390\/tomography11030026"},{"issue":"1","key":"17115_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41523-020-00203-7","volume":"6","author":"W Li","year":"2020","unstructured":"Li W, Newitt DC, Gibbs J, Wilmes LJ, Jones EF, Arasu VA, et al. Predicting breast cancer response to neoadjuvant treatment using multi-feature MRI: results from the I-SPY 2 TRIAL. NPJ Breast Cancer. 2020;6(1):63. https:\/\/doi.org\/10.1038\/s41523-020-00203-7.","journal-title":"NPJ Breast Cancer"},{"issue":"4","key":"17115_CR22","doi-asserted-by":"publisher","first-page":"e220126","DOI":"10.1148\/rycan.220126","volume":"5","author":"N Onishi","year":"2023","unstructured":"Onishi N, Bareng TJ, Gibbs J, Li W, Price ER, Joe BN, et al. Effect of Longitudinal Variation in Tumor Volume Estimation for MRI-guided Personalization of Breast Cancer Neoadjuvant Treatment. Radiol Imaging Cancer. 2023;5(4):e220126. https:\/\/doi.org\/10.1148\/rycan.220126.","journal-title":"Radiol Imaging Cancer"},{"key":"17115_CR23","doi-asserted-by":"publisher","first-page":"111649","DOI":"10.1016\/j.ejrad.2024.111649","volume":"178","author":"P Kapetas","year":"2024","unstructured":"Kapetas P, Aggarwal R, Altuwayjiri B, Pinker K, Clauser P, Helbich TH, et al. A model combining BI-RADS\u00ae descriptors from pre-treatment B-mode breast ultrasound with clinicopathological tumor features shows promise in the prediction of residual disease after neoadjuvant chemotherapy. Eur J Radiol. 2024;178:111649. https:\/\/doi.org\/10.1016\/j.ejrad.2024.111649.","journal-title":"Eur J Radiol"},{"issue":"3","key":"17115_CR24","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1159\/000521638","volume":"17","author":"P Chen","year":"2022","unstructured":"Chen P, Wang C, Lu R, Pan R, Zhu L, Zhou D, et al. Multivariable Models Based on Baseline Imaging Features and Clinicopathological Characteristics to Predict Breast Pathologic Response after Neoadjuvant Chemotherapy in Patients with Breast Cancer. Breast Care (Basel). 2022;17(3):306\u201315. https:\/\/doi.org\/10.1159\/000521638.","journal-title":"Breast Care (Basel)"},{"key":"17115_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s10278-026-01946-8","author":"W Zhang","year":"2026","unstructured":"Zhang W, Sun W, Li Y, Zhu Y, Li B. Multimodal Imaging-Based Prediction of Pathological Complete Response After Neoadjuvant Chemotherapy for Breast Cancer. J Imaging Inf Med. 2026. https:\/\/doi.org\/10.1007\/s10278-026-01946-8.","journal-title":"J Imaging Inf Med"},{"issue":"3","key":"17115_CR26","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1245\/s10434-015-4918-0","volume":"23","author":"B Schaefgen","year":"2016","unstructured":"Schaefgen B, Mati M, Sinn HP, Golatta M, Stieber A, Rauch G, et al. Can Routine Imaging After Neoadjuvant Chemotherapy in Breast Cancer Predict Pathologic Complete Response? Ann Surg Oncol. 2016;23(3):789\u201395. https:\/\/doi.org\/10.1245\/s10434-015-4918-0.","journal-title":"Ann Surg Oncol"},{"key":"17115_CR27","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.2147\/cmar.S247279","volume":"12","author":"K Zhang","year":"2020","unstructured":"Zhang K, Li J, Zhu Q, Chang C. Prediction of Pathologic Complete Response by Ultrasonography and Magnetic Resonance Imaging After Neoadjuvant Chemotherapy in Patients with Breast Cancer. Cancer Manag Res. 2020;12:2603\u201312. https:\/\/doi.org\/10.2147\/cmar.S247279.","journal-title":"Cancer Manag Res"},{"issue":"3","key":"17115_CR28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10549-005-2510-1","volume":"92","author":"AF Schott","year":"2005","unstructured":"Schott AF, Roubidoux MA, Helvie MA, Hayes DF, Kleer CG, Newman LA, et al. Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy. Breast Cancer Res Treat. 2005;92(3):231\u20138. https:\/\/doi.org\/10.1007\/s10549-005-2510-1.","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"17115_CR29","doi-asserted-by":"publisher","first-page":"7421","DOI":"10.1245\/s10434-021-10117-8","volume":"28","author":"FK Palshof","year":"2021","unstructured":"Palshof FK, Lanng C, Kroman N, Benian C, Vejborg I, Bak A, et al. Prediction of Pathologic Complete Response in Breast Cancer Patients Comparing Magnetic Resonance Imaging with Ultrasound in Neoadjuvant Setting. Ann Surg Oncol. 2021;28(12):7421\u20139. https:\/\/doi.org\/10.1245\/s10434-021-10117-8.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"17115_CR30","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/s1470-2045(07)70278-4","volume":"8","author":"DN Krag","year":"2007","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007;8(10):881\u20138. https:\/\/doi.org\/10.1016\/s1470-2045(07)70278-4.","journal-title":"Lancet Oncol"},{"issue":"10","key":"17115_CR31","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/s1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927\u201333. https:\/\/doi.org\/10.1016\/s1470-2045(10)70207-2.","journal-title":"Lancet Oncol"},{"issue":"1","key":"17115_CR32","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1186\/s12885-018-4760-4","volume":"18","author":"J Heil","year":"2018","unstructured":"Heil J, Sinn P, Richter H, Pfob A, Schaefgen B, Hennigs A, et al. RESPONDER - diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer - a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial. BMC Cancer. 2018;18(1):851. https:\/\/doi.org\/10.1186\/s12885-018-4760-4.","journal-title":"BMC Cancer"},{"issue":"7","key":"17115_CR33","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1001\/jamasurg.2025.1072","volume":"160","author":"M Basik","year":"2025","unstructured":"Basik M, Cecchini RS, De Los Santos JF, Umphrey HR, Julian TB, Mamounas EP, et al. Breast Tumor-Bed Biopsy for Pathological Complete Response Prediction: The NRG-BR005 Nonrandomized Clinical Trial. JAMA Surg. 2025;160(7):723\u201331. https:\/\/doi.org\/10.1001\/jamasurg.2025.1072.","journal-title":"JAMA Surg"},{"key":"17115_CR34","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ejca.2020.11.006","volume":"143","author":"A Pfob","year":"2021","unstructured":"Pfob A, Sidey-Gibbons C, Lee HB, Tasoulis MK, Koelbel V, Golatta M, et al. Identification of breast cancer patients with pathologic complete response in the breast after neoadjuvant systemic treatment by an intelligent vacuum-assisted biopsy. Eur J Cancer. 2021;143:134\u201346. https:\/\/doi.org\/10.1016\/j.ejca.2020.11.006.","journal-title":"Eur J Cancer"},{"issue":"18","key":"17115_CR35","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1016\/j.ejca.2012.05.023","volume":"48","author":"N Houssami","year":"2012","unstructured":"Houssami N, Macaskill P, von Minckwitz G, Marinovich ML, Mamounas E. Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy. Eur J Cancer. 2012;48(18):3342\u201354. https:\/\/doi.org\/10.1016\/j.ejca.2012.05.023.","journal-title":"Eur J Cancer"},{"key":"17115_CR36","doi-asserted-by":"publisher","unstructured":"Spiegelhalter DJ. Probabilistic prediction in patient management and clinical trials. Stat Med. 1986 Sep-Oct;5(5):421-33. https:\/\/doi.org\/10.1002\/sim.4780050506","DOI":"10.1002\/sim.4780050506"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-17115-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-17115-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-17115-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:39:46Z","timestamp":1792028386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-17115-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["17115"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-17115-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and its subsequent amendments and was approved by the local ethics committee at University of Heidelberg (Ethics Committee approval number: S-326\/2022). Due to the retrospective nature of the study, the ethics committee waived the requirement for informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1229"}}